Columbia, MD, United States of America

Alan R Shuldiner

USPTO Granted Patents = 16 

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 42(Granted Patents)


Location History:

  • Columbia, MD (US) (1998 - 2011)
  • Baltimore, MD (US) (2019 - 2022)
  • Tarrytown, NY (US) (2020 - 2023)

Company Filing History:


Years Active: 1998-2023

Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Alan R Shuldiner

Introduction: Alan R Shuldiner, a prominent inventor based in Columbia, MD, has made significant strides in the field of genetics and biomedicine. With a portfolio of 16 patents to his name, Shuldiner has focused his research on important genetic variants and their implications for human health. His contributions have not only advanced scientific knowledge but also opened doors for potential therapeutic applications.

Latest Patents: Among his noteworthy inventions, Shuldiner's latest patents involve HSD17B13 variants and their uses. These patents encompass compositions related to HSD17B13 variants, including nucleic acid molecules and polypeptides, as well as methods for detecting specific variants and assessing susceptibility to liver diseases. Specifically, his work includes methods for detecting the presence of the HSD17B13 rs72613567 variant in genomic DNA and the levels of various HSD17B13 transcripts and protein isoforms in biological samples. These innovations hold promise for improving diagnostics and understanding liver disease development.

Career Highlights: Shuldiner's career has been marked by his tenure at esteemed institutions such as the University of Maryland, Baltimore and Regeneron Pharmaceuticals, Inc. His research efforts at these organizations have fostered advances in genetic research, contributing to the broader understanding of genetic factors that influence health conditions.

Collaborations: Throughout his career, Shuldiner has collaborated with notable colleagues, including Da-Wei Gong and Noura S Abul-Husn. These partnerships have been instrumental in driving forward innovative research initiatives and developing practical applications of his discoveries.

Conclusion: Alan R Shuldiner's work exemplifies the impact that dedicated inventors can have on science and medicine. With his continued focus on HSD17B13 variants, he is paving the way for future advancements that may transform the diagnosis and treatment of liver diseases. His contributions are invaluable to the field, reflecting a commitment to innovation and discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…